Top Cities for Friedreich Ataxia Clinical Trials
Friedreich Ataxia clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Friedreich Ataxia
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
Clinical trials are advancing new treatments for friedreich ataxia. Currently, 1 studies are recruiting a combined 255 participants across the United States. Research is being conducted by 1 organizations including Biogen.
2026 Friedreich Ataxia Research Landscape
As of March 2026, the friedreich ataxia clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 255 participants, with an average enrollment target of 255 per study.
Research is being led by 1 organization, including Biogen.
Geographically, friedreich ataxia trials are most concentrated in Los Angeles, California (1 trial); Gainesville, Florida (1 trial); Tampa, Florida (1 trial); Philadelphia, Pennsylvania (1 trial); Memphis, Tennessee (1 trial) and 5 other cities.
Featured Friedreich Ataxia Studies
Highlighted recruiting studies for friedreich ataxia, selected by enrollment size and research scope.
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
In this study, researchers will learn more about the effects and safety of BIIB141, also known as omaveloxolone or SKYCLARYS®. This drug has been approved, or made available for doctors to prescribe, for people with Friedreich's Ataxia (FA) who are at least 16 years old. But, it is not yet available for children and teens with FA who are younger than 16 years old. The main objective of this study ...
Frequently Asked Questions About Friedreich Ataxia Clinical Trials
Are there friedreich ataxia clinical trials near me?
Yes, there are 1 friedreich ataxia clinical trials currently recruiting across 10+ cities in the United States, including Los Angeles, California; Gainesville, Florida; Tampa, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a friedreich ataxia clinical trial?
To join a friedreich ataxia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are friedreich ataxia clinical trials free?
Yes, participation in friedreich ataxia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of friedreich ataxia treatments are being studied?
Current friedreich ataxia clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in friedreich ataxia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov